首页> 外文期刊>Hormone and Metabolic Research >Coagulation Profile in Patients with Different Etiologies for Cushing Syndrome: A Prospective Observational Study
【24h】

Coagulation Profile in Patients with Different Etiologies for Cushing Syndrome: A Prospective Observational Study

机译:不同病因患者对缓冲综合征的患者的凝血概况:一个前瞻性观察研究

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies reported a higher prevalence of venous-thromboembolic events among patients with Cushing disease (CD) compared to those with ACTH-independent Cushing syndrome (CS) from adrenal sources. The objective of the current study was to evaluate the coagulation profile of patients with CS from different etiologies. A prospective observational study was conducted at a clinical research center. The study included adult patients admitted for evaluation of suspected CS (n = 85), that were divided into 3 groups: CD (n = 22), ACTH-independent CS from an adrenal tumor/hyperplasia (adrenal CS, n = 21), and a control group consisting of subjects with negative screening for CS (rule-out CS, n = 42). Coagulation profiles were drawn before and 8.5 +/- 4.3 months after surgery (trans-sphenoidal or adrenalectomy, n = 18), and included fibrinogen, Factor VIII (FVIII), von Willebrand factor antigen (vWF: Ag), plasminogen activator inhibitor-1 (PAI-1), antithrombin III (ATIII), Protein C (PC), Protein S (PS), alpha 2-antiplasmin (alpha 2AP), and aPTT measurements. Patients with CD had higher baseline mean cortisol levels, ATIII activity and vWF: Ag levels compared with adrenal CS. Differences in ATIII activity and vWF: Ag levels remained even after controlling for BMI, and ATIII after also controlling for 24-h urinary free cortisol collections. Our study showed for the first time the differences in coagulation profiles between various etiologies of CS. We assume that the higher cortisol burden among CD patients may explain the differences found in the coagulation profile as well as the higher risk for VTE compared with primary adrenal CS patients.
机译:以前的研究报告,与来自肾上腺源的独立独立的缓冲综合征(CS)的患者相比,缓冲疾病(CD)中的静脉血栓栓塞事件的患病率较高。目前研究的目的是评估来自不同病因的CS患者的凝血剖面。在临床研究中心进行了一项潜在观察研究。该研究包括入备疑似Cs(n = 85)评估的成年患者,其分为3组:Cd(n = 22),来自肾上腺肿瘤/增生的actH无关的Cs(肾上腺Cs,n = 21),和由对CS阴性筛选的受试者组成的对照组(排除CS,n = 42)。在手术后(Trans-sphenoidal或肾上腺切除术,N = 18)之前绘制凝血型材和8.5 +/- 4.3个月,并包括纤维蛋白原,因子VIII(FVIII),von Willebrand因子抗原(VWF:AG),纤溶酶原激活剂抑制剂 - 1(PAI-1),抗凝血酶III(ATIII),蛋白C(PC),蛋白质S(PS),α2-抗催化剂(α2AP)和APTT测量。镉患者具有更高的基线平均皮质醇水平,ATIII活性和VWF:AG水平与肾上腺Cs相比。甚至在控制BMI后,ATIII活性和VWF的差异仍然存在,并且在控制24-H尿液中的皮质醇收集后ATIII仍然存在。我们的研究表明,首次CS各种病因之间的凝固谱的差异。我们假设CD患者的较高的皮质醇负担可以解释凝血型材中发现的差异以及与原发性肾上腺CS患者相比的vTE的风险较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号